Stock 0NEX ORPEA
Add to a list
To use this feature you must be a member
Log inSign up

Financials ORPEA London S.E.

Equities

0NEX

FR0000184798

Healthcare Facilities & Services

Market Closed - London S.E.
Other stock markets
 11:30:00 2024-05-31 am EDT 		5-day change 1st Jan Change
12.85 EUR +1.58% Intraday chart for ORPEA -10.92% -23.51%
May. 15 ORPEA : Challenging recovery in France, adequate elsewhere Alphavalue
May. 15 Oddo BHF Upgrades Emeis to Neutral from Underperform, Lifts PT MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,380 6,946 5,691 398.9 2,195 2,060 - -
Enterprise Value (EV) 1 14,710 15,239 16,866 12,926 2,195 9,570 8,269 6,851
P/E ratio 32.7 x 44.1 x 87.2 x -0.1 x 130 x -0.01 x -0.01 x 0.02 x
Yield 1.14% 0.84% - - - - - 6,569%
Capitalization / Revenue 1.97 x 1.77 x 1.33 x 0.09 x 0.42 x 0.37 x 0.34 x 0.32 x
EV / Revenue 3.93 x 3.89 x 3.94 x 2.76 x 0.42 x 1.7 x 1.38 x 1.08 x
EV / EBITDA 15.5 x 16.4 x 16.3 x 17.1 x - 12.2 x 8.81 x 6.88 x
EV / FCF -70 x -72.2 x 32.6 x 51.5 x - 23.5 x 10.2 x 5.81 x
FCF Yield -1.43% -1.38% 3.07% 1.94% - 4.26% 9.8% 17.2%
Price to Book 2.45 x 1.99 x 1.5 x -0.27 x - 0 x 0 x 0 x
Nbr of stocks (in thousands) 64.6 64.6 64.6 64.6 129,867 159,192 - -
Reference price 2 114,300 107,550 88,100 6,172 16.90 12.94 12.94 12.94
Announcement Date 3/17/20 3/16/21 3/11/22 5/12/23 5/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,740 3,922 4,285 4,681 5,198 5,631 5,994 6,349
EBITDA 1 949.4 926.5 1,037 756 - 786.4 938.1 995.3
EBIT 1 503.7 422.9 395.7 -49 - -6.8 100.9 -
Operating Margin 13.47% 10.78% 9.24% -1.05% - -0.12% 1.68% -
Earnings before Tax (EBT) 1 325.7 210.3 105.8 -4,591 1,400 -30 - -
Net income 1 233.8 160 65.18 -4,027 1,355 -291.6 -175.2 136
Net margin 6.25% 4.08% 1.52% -86.03% 26.07% -5.18% -2.92% 2.14%
EPS 2 3,492 2,440 1,010 -62,330 0.1300 -1,670 -900.0 860.0
Free Cash Flow 1 -210 -211 517 251 - 407.5 810.4 1,180
FCF margin -5.61% -5.38% 12.06% 5.36% - 7.24% 13.52% 18.58%
FCF Conversion (EBITDA) - - 49.85% 33.2% - 51.82% 86.38% 118.54%
FCF Conversion (Net income) - - 793.1% - - - - 867.5%
Dividend per Share 2 1,300 900.0 - - - - - 850.0
Announcement Date 3/17/20 3/16/21 3/11/22 5/12/23 5/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 1,904 2,018 2,069 1,110 1,148 1,192 2,312 1,181 1,234 1,305
EBITDA - - - - - - - - - -
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 7/21/20 3/16/21 7/20/21 11/3/21 5/5/22 7/20/22 7/20/22 11/8/22 8/7/23 11/7/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 7,330 8,293 11,175 12,527 - 7,510 6,209 4,791
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 7.721 x 8.951 x 10.78 x 16.57 x - 9.55 x 6.619 x 4.814 x
Free Cash Flow 1 -210 -211 517 251 - 408 810 1,180
ROE (net income / shareholders' equity) 7.8% 5.01% 1.79% - - -11.4% -7.3% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 46,678 54,090 58,825 -23,236 - 15,015 14,620 15,060
Cash Flow per Share 2 6,586 11,382 11,679 6,342 - 309,320 - -
Capex 1 651 915 1,271 159 - 198 210 -
Capex / Sales 17.41% 23.33% 29.66% 3.39% - 3.52% 3.51% -
Announcement Date 3/17/20 3/16/21 3/11/22 5/12/23 5/7/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for ORPEA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.94 EUR
Average target price
11,725 EUR
Spread / Average Target
+90,510.51%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Residential & Long-Term Care

1st Jan change Capi.
NATIONAL HEALTHCARE CORPORATION Stock National HealthCare Corporation
+14.42% 1.62B
AMVIS HOLDINGS, INC. Stock Amvis Holdings, Inc.
-34.18% 1.23B
SIENNA SENIOR LIVING INC. Stock Sienna Senior Living Inc.
+24.98% 765M
ARVIDA GROUP LIMITED Stock Arvida Group Limited
-12.73% 425M
SONIDA SENIOR LIVING, INC. Stock Sonida Senior Living, Inc.
+186.13% 363M
MEDITERRANEAN TOWERS LTD. Stock Mediterranean Towers Ltd.
-8.94% 327M
HUMANA AB Stock Humana AB
+15.10% 147M
GOLDEN HOUSE LTD Stock Golden House Ltd
+20.06% 78.93M
Residential & Long-Term Care
  1. Stock Market
  2. Equities
  3. ORP Stock
  4. 0NEX Stock
  5. Financials ORPEA